CD44 and breast cancer: However, no guidelines currently exist for defining a CTC-CSC phenotype, although a common classification of CSCs of high CD44 and low CD24 expression (CD44+/CD24−/low), is frequently utilised in breast cancer, and breast tumours with this expression tend to exhibit enhanced invasion and metastasis [40].